Ann M. O’Mara

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell et al. · JNCI Journal of the National Cancer Institute · 2014 · 1.1K citations · Full text

Pharmacy, Oncology, Cancer Control +15

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell et al. · JAMA Oncology · 2015 · 1K citations · Full text

Pharmacy, Oncology, Outcomes Research +13

Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors

Xin Shelley Wang, Fengmin Zhao, Michael Fisch et al. · Cancer · 2013 · 368 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +12

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

Andrew L. Himelstein, Jared C. Foster, James Khatcheressian et al. · JAMA · 2017 · 357 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study

Charles S. Cleeland, Fengmin Zhao, Victor T. Chang et al. · Cancer · 2013 · 313 citations · Full text

Medicine, Oncology, Breast Oncology +16